Lxbio Phar­ma­ceu­ti­cals is pleased to announce that an invest­ment agree­ment has been signed with Explor­er SCR, a lead­ing invest­ment Fund in Por­tu­gal, an invest­ment with a glob­al amount of 6 Mil­lion Euros, name­ly, to sup­port Lxbio research & devel­op­ment projects.

Mes­sage from Lxbio CEO

We are proud to announce a new part­ner­ship that promise to open new avenues for research and inno­va­tion. This col­lab­o­ra­tion will lever­age cut­ting-edge tech­nol­o­gy and shared knowl­edge to tack­le press­ing glob­al health and envi­ron­men­tal issues.

Our part­ner­ships across aca­d­e­m­ic insti­tu­tions, indus­try lead­ers, and research orga­ni­za­tions are a tes­ta­ment to our belief in the pow­er of col­lab­o­ra­tion. These alliances not only ampli­fy our capa­bil­i­ties but also accel­er­ate our jour­ney towards ground­break­ing dis­cov­er­ies.

Let us con­tin­ue to be curi­ous, to chal­lenge the sta­tus quo, and to pur­sue excel­lence in all our endeav­ors. Togeth­er, we will rede­fine what’s pos­si­ble.

Togeth­er for­ward,

Car­los Paula

Leave a Reply

Your email address will not be published. Required fields are marked *